Zurcher Kantonalbank Zurich Cantonalbank Boosts Holdings in Cameco Co. (NYSE:CCJ)

Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Cameco Co. (NYSE:CCJFree Report) (TSE:CCO) by 3.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 264,343 shares of the basic materials company’s stock after purchasing an additional 8,909 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Cameco were worth $13,585,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in CCJ. Sierra Ocean LLC bought a new position in shares of Cameco during the fourth quarter worth $25,000. Bank Julius Baer & Co. Ltd Zurich purchased a new stake in Cameco in the 4th quarter worth $28,000. Pingora Partners LLC bought a new position in shares of Cameco during the 3rd quarter valued at about $33,000. Whipplewood Advisors LLC purchased a new position in shares of Cameco during the fourth quarter valued at about $33,000. Finally, Compass Planning Associates Inc purchased a new position in shares of Cameco during the fourth quarter valued at about $36,000. 70.21% of the stock is owned by hedge funds and other institutional investors.

Cameco Stock Performance

NYSE CCJ opened at $42.63 on Thursday. The business’s 50 day moving average price is $48.22 and its 200-day moving average price is $49.96. Cameco Co. has a fifty-two week low of $35.43 and a fifty-two week high of $62.55. The company has a market cap of $18.56 billion, a P/E ratio of 152.23 and a beta of 1.04. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.26 and a current ratio of 2.88.

Cameco (NYSE:CCJGet Free Report) (TSE:CCO) last posted its quarterly earnings data on Thursday, February 20th. The basic materials company reported $0.26 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.26. The business had revenue of $845.54 million for the quarter, compared to analysts’ expectations of $1.09 billion. Cameco had a net margin of 5.39% and a return on equity of 4.34%. Sell-side analysts predict that Cameco Co. will post 1.27 earnings per share for the current year.

Analyst Ratings Changes

CCJ has been the subject of a number of research reports. Royal Bank of Canada reissued an “outperform” rating and set a $90.00 price target on shares of Cameco in a research note on Tuesday, March 4th. Glj Research increased their target price on Cameco from $62.76 to $75.68 and gave the company a “buy” rating in a research report on Wednesday. Stifel Nicolaus assumed coverage on shares of Cameco in a report on Wednesday. They issued a “buy” rating for the company. Finally, StockNews.com downgraded shares of Cameco from a “hold” rating to a “sell” rating in a research note on Tuesday. One research analyst has rated the stock with a sell rating, seven have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $73.64.

Check Out Our Latest Analysis on CCJ

Cameco Company Profile

(Free Report)

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.

Further Reading

Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Co. (NYSE:CCJFree Report) (TSE:CCO).

Institutional Ownership by Quarter for Cameco (NYSE:CCJ)

Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.